|
2016 Journal Article Rapid molecular profiling of myeloproliferative neoplasms using targeted Exon Resequencing of 86 genes involved in JAK-STAT signaling and epigenetic regulationMagor, Graham W., Tallack, Michael R., Klose, Nathan M., Taylor, Debra, Korbie, Darren, Mollee, Peter, Trau, Matt and Perkins, Andrew C. (2016). Rapid molecular profiling of myeloproliferative neoplasms using targeted Exon Resequencing of 86 genes involved in JAK-STAT signaling and epigenetic regulation. Journal of Molecular Diagnostics, 18 (5), 707-718. doi: 10.1016/j.jmoldx.2016.05.006 |
|
2016 Journal Article Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversiesTate, Jillian R., Graziani, Maria Stella, Mollee, Peter and Merlini, Giampaolo (2016). Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies. Clinical Chemistry and Laboratory Medicine, 54 (6), 899-905. doi: 10.1515/cclm-2016-0268 |
|
2016 Journal Article Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisMollee, Peter and Merlini, Giampaolo (2016). Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 54 (6), 921-927. doi: 10.1515/cclm-2015-0938 |
|
2016 Journal Article Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysisKennard, Alice, Hawley, Carmel, Tate, Jill, Klingberg, Sandra, Pretorius, Carel, Hutchison, Colin and Mollee, Peter (2016). Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis. Clinical Chemistry and Laboratory Medicine, 54 (6), 1045-1052. doi: 10.1515/cclm-2015-0799 |
|
2016 Journal Article Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexesBurgess, M., Ellis, J. J., Mapp, S., Mollee, P., Mazzieri, R., Mattarollo, S. R., Gill, D. and Saunders, N. A. (2016). Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes. Genomics Data, 7, 4-6. doi: 10.1016/j.gdata.2015.11.010 |
|
2015 Conference Publication Emergence of Fc-Gamma-Riib-dominance contributes to resistance to therapeutic antibodies in patients with chronic lymphocytic leukaemiaBurgess, Melinda, Mapp, Sally, Mazzieri, Roberta, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter, Gill, Devinder and Saunders, Nicholas (2015). Emergence of Fc-Gamma-Riib-dominance contributes to resistance to therapeutic antibodies in patients with chronic lymphocytic leukaemia. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL USA, 5-8 December 2015. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v126.23.447.447 |
|
2015 Conference Publication Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS/MS) proteomic analysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS/MS) proteomic analysis. 57th ASH Annual Meeting, Orlando, FL, 5-8 December 2015. American Society of Hematology. doi: 10.1182/blood.v126.23.1779.1779 |
|
2015 Journal Article Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: An Australian retrospective analysisMillar, A., Ellis, M., Mollee, P., Cochrane, T., Fletcher, J., Caudron, A., Webster, B. and Trotman, J. (2015). Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: An Australian retrospective analysis. Internal Medicine Journal, 45 (11), 1147-1153. doi: 10.1111/imj.12889 |
|
2015 Conference Publication Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitalsMcKavanagh, Daniel, Walpole, Euan, Hollingworth, Samantha, Sharkey, Megan and Mollee, Peter (2015). Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitals. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, TAS, Australia, 17–19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2015 Journal Article Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2015). Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients. Nephrology Dialysis Transplantation, 30 (10), 1774-1779. doi: 10.1093/ndt/gfv260 |
|
2015 Conference Publication Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysisKennard, A., Hawley, C., Tate, J., Klingberg, S., Pretorius, C. and Mollee, P. (2015). Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT, Australia, 7-9 September 2015. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/nep.12543 |
|
2015 Conference Publication LECT2 Amyloidosis: not just a Hispanic diseaseRamzy, J., Mollee, P., Kwok, F., Gilbertson, J., Hosking, P., Fraenkel, M., Renaut, P., Stewart, G., Booth, D. and Gibbs, S. (2015). LECT2 Amyloidosis: not just a Hispanic disease. 15th International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.07.414 |
|
2015 Conference Publication Developing safe haematological monitoring guidelines for patients with myeloma on bortezomib based regimensWoodrow, C. and Mollee, P. (2015). Developing safe haematological monitoring guidelines for patients with myeloma on bortezomib based regimens. 15th International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.08.097 |
|
2015 Journal Article International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive b cell ptld: Clues from the ptld-1 trialTrappe, R. U., Choquet, S., Dierickx, D., Mollee, P., Zaucha, J. M., Dreyling, M. H., Duehrsen, U., Tarella, C., Shpilberg, O., Sender, M., Salles, G., Morschhauser, F., Jaccard, A., Lamy, T., Reinke, P., Neuhaus, R., Lehmkuhl, H., Horst, H. A., Leithaeuser, M., Schlattmann, P., Anagnostopoulos, I., Raphael, M., Riess, H., Leblond, V. and Oertel, S. (2015). International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive b cell ptld: Clues from the ptld-1 trial. American Journal of Transplantation, 15 (4), 1091-1100. doi: 10.1111/ajt.13086 |
|
2015 Journal Article Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupWeber, N., Mollee, P., Augustson, B., Brown, R., Catley, L., Gibson, J., Harrison, S., Ho, P. J., Horvath, N., Jaksic, W., Joshua, D., Quach, H., Roberts, A. W., Spencer, A., Szer, J., Talaulikar, D., To, B., Zannettino, A. and Prince, H. M. (2015). Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (4), 371-382. doi: 10.1111/imj.12566 |
|
2015 Journal Article Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupQuach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (3), 335-343. doi: 10.1111/imj.12688 |
|
2015 Journal Article Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupQuach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibsonm J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (1), 94-105. doi: 10.1111/imj.12640 |
|
2015 Journal Article Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchangeTate, Courtney and Mollee, Peter (2015). Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchange. Medical Journal of Australia, 202 (6), 330-332. doi: 10.5694/mja14.01125 |
|
2015 Conference Publication Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patientsBurgess, Melinda, Gill, Devinder, Mapp, Sally, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter and Saunders, Nicholas (2015). Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patients. XVI International Workshop on Chronic Lymphocytic Leukaemia 2015, Sydney, NSW, Australia, 6–9 September 2015. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. |
|
2015 Conference Publication Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic Analysis. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. |
